VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection

Markus Rasanen, Joni Degerman, Tuuli A. Nissinen, Ilkka Miinalainen, Risto Kerkela, Antti Siltanen, Janne T. Backman, Eero Mervaala, Juha Hulmi, Riikka Kivela, Kari Alitalo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalProceedings of the National Academy of Sciences of the United States of America
Volume113
Issue number46
Pages (from-to)13144-13149
Number of pages6
ISSN0027-8424
DOIs
Publication statusPublished - 15 Nov 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • VEGFB
  • heart
  • cancer
  • endothelial cell
  • heart failure
  • GROWTH-FACTOR-B
  • DNA-DAMAGE
  • DILATED CARDIOMYOPATHY
  • MYOCARDIAL-INFARCTION
  • CANCER-PATIENTS
  • HEART-FAILURE
  • PATHWAY
  • DISEASE
  • CARDIOMYOCYTES
  • VEGF-B-167
  • 3111 Biomedicine

Cite this